361 Capital’s Endo International plc ENDP Stock Holding History

361 Capital’s Portfolio ENDP Stock Details ENDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,080	Closed	-$47K	–	407
2019 Q4	$47K	Buy	+10,080	New	+$45K	0.01%	301

Other funds holding ENDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

361 Capital's ENDP Position: Q1 2020 in Review

361 Capital sold out of Endo International plc (ENDP) in Q1 2020, closing a stake of 10,080 shares — an estimated $47K sold.

361 Capital first reported a position in ENDP in Q4 2019 and held it in 1 quarter. The position peaked at $47K in Q4 2019. 185 funds tracked by Wall St. Rank hold ENDP as of Q1 2020.

361 Capital reported no remaining Endo International plc position as of Q1 2020 after selling out during the quarter.
361 Capital sold 10,080 Endo International plc shares in Q1 2020, an estimated $47K.
361 Capital first reported a position in Endo International plc in Q4 2019 and held it in 1 quarter.
361 Capital's Endo International plc position peaked at $47K in Q4 2019.
185 funds tracked by Wall St. Rank held Endo International plc as of Q1 2020.

Based on 361 Capital's 13F filing for Q1 2020, filed 13 May 2020.